Cargando…

Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity

SIMPLE SUMMARY: The residual cancer burden (RCB) score provides prognostic information on the survival of breast cancer patients who underwent neoadjuvant systemic therapy, with the greatest impact of higher scores on worse recurrence-free survival (RFS) and overall survival (OS) in triple-negative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suppan, Christoph, Posch, Florian, Mueller, Hannah Deborah, Mischitz, Nina, Steiner, Daniel, Klocker, Eva Valentina, Setaffy, Lisa, Bargfrieder, Ute, Hammer, Robert, Hauser, Hubert, Jost, Philipp J., Dandachi, Nadia, Lax, Sigurd, Balic, Marija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161089/ https://www.ncbi.nlm.nih.gov/pubmed/34065332 http://dx.doi.org/10.3390/cancers13102492

Ejemplares similares

Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy
por: Müller, Hannah Deborah, et al.
Publicado: (2019)

COVID-19 autopsies: Procedure, technical aspects and cause of fatal course. Experiences from a single-center
por: Skok, Kristijan, et al.
Publicado: (2021)

Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR(+) breast cancer patients undergoing CDK4/6 treatment
por: Dandachi, Nadia, et al.
Publicado: (2020)

Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression
por: Brcic, Iva, et al.
Publicado: (2023)

Systemische Auswirkungen und klinische Aspekte der SARS-CoV-2-Infektion
por: Lax, Sigurd F., et al.
Publicado: (2021)

Genetic profiling of putative breast cancer stem cells from malignant pleural effusions
por: Tiran, Verena, et al.
Publicado: (2017)

Deciphering the molecular landscape of metastatic lobular breast cancer
por: Dandachi, Nadia, et al.
Publicado: (2022)

Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016
por: Suppan, Christoph, et al.
Publicado: (2017)

Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment
por: Suppan, Christoph, et al.
Publicado: (2019)

Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell Phenotype
por: Čipak Gašparović, Ana, et al.
Publicado: (2019)

Rectal Cancer Tissue Lipidome Differs According to Response to Neoadjuvant Therapy
por: Sánchez-Vinces, Salvador, et al.
Publicado: (2023)

Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy
por: Suppan, Christoph, et al.
Publicado: (2015)

Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
por: Zhou, Qing, et al.
Publicado: (2022)

It is time to prepare for D-CARE!
por: Suppan, Christoph, et al.
Publicado: (2020)

Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients
por: Benezeder, Theresa, et al.
Publicado: (2017)

Neoadjuvant Treatment for Gastric Cancer
por: Schuhmacher, Christoph, et al.
Publicado: (2013)

Neoadjuvant Chemotherapy for Colon Cancer
por: Roth, Marc T., et al.
Publicado: (2020)

Neoadjuvant Treatment in Pancreatic Cancer
por: Oba, Atsushi, et al.
Publicado: (2020)

Neoadjuvant therapy for pancreatic cancer
por: Gugenheim, Jean, et al.
Publicado: (2021)

Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients
por: Warnecke-Eberz, Ute, et al.
Publicado: (2020)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

Magnetic resonance imaging features of breast cancer according to intrinsic subtypes: correlations with neoadjuvant chemotherapy effects
por: Kawashima, Hiroko, et al.
Publicado: (2014)

Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age
por: Wu, Leilei, et al.
Publicado: (2017)

Lymph Node Status after Neoadjuvant Chemoradiation Therapy for Esophageal Cancer according to Radiation Field Coverage
por: Kim, Sang Yoon, et al.
Publicado: (2019)

Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy
por: Hamy, Anne-Sophie, et al.
Publicado: (2020)

Neoadjuvant Chemotherapy in Invasive Bladder Cancer
por: Oliver, R.T.D.
Publicado: (1991)

Neoadjuvant Therapy in Differentiated Thyroid Cancer
por: Dang, Rajan P., et al.
Publicado: (2016)

Neoadjuvant therapy for resectable pancreatic cancer
por: Rahman, Sheikh Hasibur, et al.
Publicado: (2017)

Neoadjuvant radiotherapy for rectal cancer management
por: Feeney, Gerard, et al.
Publicado: (2019)

Palbociclib in breast cancer neoadjuvant setting
por: Duarte, Sílvia Alexandra Cabral, et al.
Publicado: (2021)

Progress in neoadjuvant therapy for gastric cancer
por: Su, Peng-Fei, et al.
Publicado: (2022)

Neoadjuvant therapy for resectable pancreatic cancers
por: Inoue, Yosuke, et al.
Publicado: (2022)

Neoadjuvant and adjuvant therapy in esophageal cancer
por: Weiss, Jennifer A., et al.
Publicado: (2023)

Neoadjuvant treatment for male breast cancer
por: Fentiman, Ian Stuart
Publicado: (2023)

Neoadjuvant systemic therapy for breast cancer
por: Zaborowski, Alexandra M, et al.
Publicado: (2023)

Rapid response of breast cancer to neoadjuvant intramammary testosterone-anastrozole therapy: neoadjuvant hormone therapy in breast cancer
por: Glaser, Rebecca L., et al.
Publicado: (2014)

ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
por: Alva-Ruiz, Roberto, et al.
Publicado: (2021)

Microbial Characteristics of Locally Advanced Rectal Cancer Patients After Neoadjuvant Chemoradiation Therapy According to Pathologic Response
por: Fan, Qilin, et al.
Publicado: (2021)

Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX
por: Choi, Yoo Jin, et al.
Publicado: (2021)

Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study
por: Bulens, Philippe P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tajjc4au2i6tmrbpn2vak8lh9k